SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " SK Life Science " 6 found 🔀 AI-powered Shuffle
SK Life Science supports SUDEP awareness via partnership with CURE Epilepsy and The Cameron Boyce Foundation
SK Life Science Inc. announced Oct. 15 its support of SUDEP awareness initiatives led by CURE Epilepsy and The Cameron Boyce Foundation.
SK Life Science Supports SUDEP Awareness Efforts Through Partnership with CURE Epilepsy and The Cameron Boyce Foundation
/PRNewswire/ -- SK Life Science, Inc., a U.S. pharmaceutical company and part of SK Biopharmaceuticals, today announced its support of SUDEP awareness...
Trump Administration Releases New Government-Wide Policy to End Dangerous High-Risk Research
HHS applauds the release of the Trump Administration’s new United States Government Policy for Stopping High-Risk Life Sciences Research.
SK Life Science, Inc. Announces FDA Acceptance for Review of New Drug Application for Cenobamate Oral Suspension
Key Facts: FDA has accepted for review the New Drug Application (NDA) for an investigational oral suspension formulation of cenobamate for the treatment of...
SK Life Science, Inc. Launches Epilepsy Connect to Empower Advanced Practice Providers in Epilepsy Care
Key Facts: SK Life Science, Inc. has launched Epilepsy Connect, a new digital platform designed to empower advanced practice providers (APPs) in epilepsy care....
SK Life Science, Inc. to Present New Data and Epilepsy Insights at the 2026 American Academy of Neurology Annual Meeting
Key Facts: SK Life Science, Inc. will present multiple posters at the American Academy of Neurology (AAN) Annual Meeting (April 18–22, 2026, Chicago, Illinois)...